Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model

Area of Science:

• Oncology
• Stem Cell Biology
• Bone Cancer Research

Background:

• Osteosarcoma is the most common primary bone cancer in children and young adults.
• Its cell of origin remains debated, with theories suggesting derivation from mesenchymal stem cells (MSCs) or cells along the osteoblast differentiation pathway.

Purpose of the Study:

• To investigate whether preosteoblasts (pOB) could be the cell of origin for osteosarcoma.
• To compare the tumorigenic and differentiation properties of transformed MSCs and pOBs.

Main Methods:

• Mesenchymal stem cells (MSCs) and their differentiated preosteoblasts (pOB) were serially transformed with oncogenes (hTERT, SV40 large T antigen, H-Ras).
• Transformed cell lines were assessed for tumorigenicity in mice, histological appearance, and differentiation capacity (osteogenic, chondrogenic, adipogenic).

Main Results:

• Transformed MSCs and pOBs formed tumors in mice within 4 weeks.
• pOB-derived tumors exhibited histological features characteristic of osteosarcoma.
• Transformed pOBs lost adipogenic differentiation potential but retained osteogenic and chondrogenic potential.
• Transformed MSCs and standard osteosarcoma cell lines maintained tri-lineage differentiation capacity.

Conclusions:

• Osteosarcoma may arise from a cell intermediate in differentiation between MSCs and pOBs, with partial commitment to the osteoblastic lineage.
• The restricted differentiation capacity of transformed pOBs supports their potential role as the osteosarcoma cell of origin.